Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer

被引：1
|
作者：
Sousa, Catarina C. [1 ]
Pinto, Josue [1 ]
Martins, Natalia [1 ,2 ,3 ]
Teixeira, Sofia [4 ]
Magalhaes, Adriana [1 ]
Fernandes, Gabriela [1 ,2 ,3 ]
Hespanhol, Venceslau [1 ,2 ,3 ]
Queiroga, Henrique [1 ,2 ,3 ]
Bastos, Helder Novais [1 ,2 ,3 ]
机构：
[1] Univ Hosp Ctr Sao Joao, Dept Pulmonol, Porto, Portugal
[2] Univ Porto, Fac Med, Porto, Portugal
[3] Univ Porto, Inst Res & Innovat Hlth, Porto, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4684
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4684
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Resistance to KRAS inhibition in advanced non-small cell lung cancer
    Sreter, Katherina Bernadette
    Catarata, Maria Joana
    von Laffert, Maximilian
    Frille, Armin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] Monitoring advanced non-small cell lung cancer (NSCLC) through plasma genotyping during systemic treatment: KRAS-mutated (m) cohort results.
    Bonanno, Laura
    Zulato, Elisabetta
    Nardo, Giorgia
    Del Bianco, Paola
    Attili, Ilaria
    Pavan, Alberto
    Verza, Martina
    Pasqualini, Lorenza
    Alberti, Giulia
    Pasello, Giulia
    Zago, Giulia
    Frega, Stefano
    Fassan, Matteo
    Rugge, Massimo
    De Salvo, Gian Luca
    Calabrese, Fiorella
    Conte, Pier Franco
    Indraccolo, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Response to first-line pembrolizumab in metastatic KRAS-mutated non-small-cell lung cancer
    Rossi, Sabrina
    Pagliaro, Arianna
    Finocchiaro, Giovanna
    Marinello, Arianna
    Giordano, Laura
    Bria, Emilio
    Stefani, Alessio
    Vitale, Antonio
    Toschi, Luca
    D'Argento, Ettore
    Santoro, Armando
    FUTURE ONCOLOGY, 2024, 20 (07) : 373 - 380
  • [35] Using natural compounds to target KRAS mutated non-small cell lung cancer
    Niloy, Mahruba Sultana
    Shakil, Md Salman
    Alif, Md Meharab Hassan
    Rosengren, Rhonda J.
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (39) : 8098 - 8115
  • [36] Molecular Characterization and Prognosis of Patients with KRAS Mutant Non-small Cell Lung Cancer
    Gutierrez Sainz, L.
    Villamayor, J.
    Higuera, O.
    Cruz Castellanos, P.
    Vinal Lozano, D.
    Esteban Rodriguez, I.
    Regojo, R. M.
    Pelaez Garcia, A.
    Heredia Soto, V.
    Mendiola, M.
    Rosas Alonso, R.
    Rodriguez Antolin, C.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S620 - S621
  • [37] Outcomes of KRAS mutated, EGFR mutated, ALK mutated and wildtype patients in non-small cell lung cancer brain metastases.
    Rauf, Yasmeen
    Tatineni, Vineeth
    Oshea, Patrick Joseph
    Jia, Xuefei
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)
    Dehem, Agathe
    Mazieres, Julien
    Chour, Ali
    Guisier, Florian
    Ferreira, Marion
    Boussageon, Maxime
    Girard, Nicolas
    Moro-Sibilot, Denis
    Cadranel, Jacques
    Zalcmanl, Gerard
    Ricordel, Charles
    Wislez, Marie
    Munck, Camille
    Poulet, Claire
    Gauvain, Clement
    Descarpentries, Clotilde
    Wasielewski, Eric
    Cortot, Alexis B.
    Baldacci, Simon
    LUNG CANCER, 2023, 186
  • [39] Pooled Mutant KRAS-Targeted Peptide Vaccine with Nivolumab and Ipilimumab in Advanced KRAS Mutated Non-Small Cell Lung Cancer
    Rosner, S.
    Zaidi, N.
    Wang, H.
    Smith, K.
    Nauroth, J.
    Guo, M.
    Fitzpatrick, P.
    Riemer, J.
    Barnes, A.
    Wenga, P.
    Feliciano, J.
    Hann, C.
    Lam, V.
    Murray, J.
    Scott, S.
    Anagnostou, V.
    Levy, B.
    Forde, P.
    Brahmer, J.
    Jaffee, E.
    Marrone, K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S382 - S383
  • [40] Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer
    Judd, Julia
    Karim, Nagla Abdel
    Khan, Hina
    Naqash, Abdul Rafeh
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes Jr, Gilberto de Lima
    Spira, Alexander I.
    Korn, W. Michael
    Kim, Edward S.
    Liu, Stephen V.
    Borghaei, Hossein
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2577 - 2584
12345